Crohn’s disease is hard to manage and expensive when care is not consistent. Patients can move quickly from stability to severe flare. When that happens, many need emergency care or a hospital stay.
In the U.S., an estimated 2.4 to 3.1 million people are living with inflammatory bowel disease (IBD), including Crohn’s disease. This number continues to rise, along with the cost of care.
Biologic infusion therapy helps control moderate to severe Crohn’s disease. But where and how that care is delivered matters.
When infusions are delivered at home, common care gaps are reduced. Patients are more likely to stay on schedule, avoid flares and remain stable. For health systems, specialty pharmacies and payors, this supports stronger quality metrics and a lower total cost of care.
The Challenges of Managing Crohn’s Disease
Disease Burden and Flare Frequency
Crohn’s disease is a lifelong condition that requires ongoing care. Patients often move between periods of remission and flare.
Flares can be serious and may include:
- Severe abdominal pain
- Frequent diarrhea
- Fatigue and weight loss
- Complications that require urgent care
These episodes often lead to emergency department visits or hospital stays, where costs increase quickly.
Poorly managed Crohn’s disease can also lead to long-term complications, including strictures, fistulas (IBD complications) and the need for surgery. Each flare increases the risk of disease progression.
For health systems and payors, this results in:
- Higher inpatient volume
- Increased hospital readmissions
- Disruption in care plans
For specialty pharmacies, missed or delayed therapy can reduce treatment effectiveness and long-term adherence. When patients stay on a consistent treatment schedule, they are more likely to remain stable and avoid flares.
Barriers to Consistent Biologic Infusion Treatment
Biologic therapies must be given on a strict schedule to work as intended. Even small delays can reduce effectiveness.
Facility-based infusion creates barriers for many patients, including:
- Travel time and transportation challenges
- Limited appointment availability
- Long visits that disrupt work and daily life
- Scheduling delays due to capacity constraints
These barriers often lead to missed or delayed infusions. Over time, patients may fall out of sync with their treatment plan, increasing the risk of flare and disease progression.
For organizations, these gaps impact patient outcomes and quality metrics.
How Biologic Infusion Therapy Works at Home
Eligible Biologic Medications and Protocols
Many biologic therapies used to treat moderate to severe Crohn’s disease can be safely given in the home.
FDA-approved therapies include:
- TNF-alpha inhibitors (Infliximab)
- Integrin blockers (Entyvio and Tysabri)
- Interleukins (Stelara, Skyrizi, Omvoh and Tremfya)
These therapies may be prescribed by a gastroenterologist and follow the same clinical protocols used in healthcare facilities.
Each patient receives a structured care plan that includes:
- Defined dosing and infusion schedule
- Pre-medications when needed
- Monitoring during and after infusion
- Emergency response protocols
Standardized protocols support consistent care delivery, patient safety and treatment effectiveness.
RN-Led Administration and Patient Safety
Infusion Nursing at BrightStar Care® is delivered through RN-led care. Registered nurses manage each infusion from start to finish, including:
- Pre-infusion assessment and vital signs
- Medication preparation and administration
- Monitoring during the infusion
- Post-infusion observation and documentation
Nurses are trained to recognize and respond to adverse infusion reactions. Clear protocols guide next steps or escalation if needed.
This level of clinical oversight helps maintain strong safety standards in the home setting while ensuring consistency across all visits.
Adherence and Flare Prevention at Home
How Home Delivery Improves Medication Adherence
Medication adherence is one of the most important factors for limiting Crohn’s disease progression.
When patients miss or delay infusions, the risk of flare increases. Over time, this can lead to:
- More frequent disease flares
- Increased disease activity
- Loss of response to therapy
- Increased hospital use
- Higher total cost of care
Research shows that patients who do not remain consistent with treatments are more likely to relapse and require higher levels of care. Non-adherence has also been linked to higher healthcare costs, including more hospital visits and emergency care.
Home-based infusion helps remove common barriers to care. Patients do not need to:
- Travel to a healthcare facility
- Arrange transportation to and from appointments
- Take extended time away from work or family
Care is delivered in a familiar home setting, which supports:
- More consistent scheduling
- Fewer missed or delayed doses
- Better long-term adherence
For organizations, improved medication adherence supports stronger quality metrics and more predictable care patterns. It also helps reduce avoidable disruptions across the care continuum.
Early Intervention and Flare Mitigation
RN-led care in the home supports early intervention. During each visit, nurses assess the patient’s condition and look for early signs of worsening inflammation, such as:
- Increased frequency of diarrhea
- New or worsening urgency
- Ongoing abdominal pain or cramping
- Severe fatigue
- Fever
When these signs are identified early, care teams can act quickly. Nurses communicate findings to the prescribing provider and support next steps in the care plan. This may include adjusting treatment or scheduling follow-up care.
Addressing issues early helps reduce emergency visits and hospital admissions. This supports better patient experiences and improved cost control.
Quality Metrics and Continuity of Care
Measuring Success in Chronic Disease Infusion Programs
For B2B partners, success is measured by clear and consistent quality metrics.
Home-based infusion programs can support:
- Higher medication adherence
- Fewer disease flares
- Lower hospital use
- Fewer hospital readmissions
These metrics align with value-based care goals and payor performance measures.
They also give organizations a clear view of patient progress over time. With consistent data, care teams can track performance, identify trends and make informed decisions.
Coordination With Gastroenterology and Specialty Pharmacy Teams
Continuity of care depends on strong coordination across all teams involved in treatment.
BrightStar Care works as an extension of partner teams to support clear and consistent communication across the care journey. We use your existing systems, so teams do not need to learn new workflows or platforms.
We help keep everyone aligned by:
- Sharing documentation with providers after each visit
- Coordinating with specialty pharmacy dispensing schedules
- Supporting established gastroenterology care plans
This steady flow of information helps reduce care gaps and keeps treatment on track. It also ensures providers, pharmacy teams and care partners share the same view of patient status.
For organizations, this creates a more connected and efficient care model that supports better outcomes and smoother care delivery.
BrightStar Care’s Chronic Disease Infusion Model
Nationwide Infusion Nursing With Condition-Specific Protocols
BrightStar Care delivers biologic infusions at home in both rural and urban areas through more than 430 locations across 41 states. This model combines national reach with local clinical accountability, so care remains consistent while adapting to the needs of each patient and partner organization.
Key strengths include:
- Standardized care for chronic disease infusion therapy
- RN-led care across all locations
- Flexible capacity to support changes in patient volume
Each program is designed to support patients with complex, long-term conditions like Crohn’s disease.
Supporting Specialty Pharmacy and Health System Partners
BrightStar Care teams work alongside specialty pharmacies, healthcare facilities and payors to extend care into the home. We function as a workforce solution that acts as a seamless extension of existing care teams.
We integrate into existing workflows to support:
- Timely patient starts
- Consistent infusion scheduling
- Shared quality metrics and reporting
This approach allows organizations to expand access to care without building new infrastructure. It also helps maintain control, visibility and alignment across the care process.
Improve Adherence and Reduce the Cost of Crohn’s Disease Care
Crohn’s disease requires consistent, long-term management. When care is delayed or disrupted, the risk of flare, disease progression, higher levels of care and hospitalization increases.
Improving medication adherence and supporting early intervention helps organizations reduce avoidable hospital use and strengthen quality metrics.
BrightStar Care supports this model through RN-led Infusion Nursing, standardized protocols and coordinated care delivery. We partner with specialty pharmacies, healthcare facilities and payors to improve adherence and reduce the total cost of Crohn’s disease care.
Explore how a BrightStar Care partnership helps you safely scale at-home infusion therapy for chronic conditions in rural and urban areas.